Zobrazeno 1 - 10
of 26
pro vyhledávání: '"P. N. Grozea"'
Autor:
John D. Bonnet, James K. Weick, Albert F. LoBuglio, Harmon J. Eyre, Marcia K. Liepman, P. N. Grozea, Charles A. Coltman, Richard I. Fisher, Lyubica Dabich, Steve Dahlberg, Robert J. Hartsock
Publikováno v:
Cancer Investigation. 9:613-620
Based on a preliminary trial that suggested that CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone), and PVB (cisplatinum, vinblastine, bleomycin), are at least partially non-cross-resistant, the Southwest Oncology Group treated patients w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f39254e0dc57733fb9a8f84025e2865
https://doi.org/10.3109/07357909109039872
https://doi.org/10.3109/07357909109039872
Autor:
Carl M. Mansfield, Thomas P. Miller, Candy Seibert, Stephen E. Jones, Ellis J. Van Slyck, Komanduri M. Ayyangar, Francis S. Morrison, Carol J. Fabian, P. N. Grozea
Publikováno v:
Cancer. 66:2295-2299
The authors reviewed the records of 139 patients who had laparotomy plus computed tomography (CT) and/or lymphangiograms (LAG) as part of a their staging workup for Hodgkin's disease, in accordance with Southwest Oncology Group (SWOG) protocol 7808.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::72e9facd47e49dcd14eee4a688d72030
https://doi.org/10.1002/1097-0142(19901201)66:11<2295::aid-cncr2820661107>3.0.co
https://doi.org/10.1002/1097-0142(19901201)66:11<2295::aid-cncr2820661107>3.0.co
Autor:
P N, Grozea, J J, Crowley, V A, Canfield, L, Kingsbury, S W, Ross, G S, Beltran, L R, Laufman, G R, Weiss, R B, Livingston
Publikováno v:
Cancer. 80(6)
Teniposide (VM-26) was reported to have activity in small cell lung carcinoma (SCLC). The authors performed a Phase II study of teniposide as a treatment for patients with previously untreated extensive SCLC.The study was open to patients with a hist
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9288200fa966e0534f4f9bf5e1769e52
https://pubmed.ncbi.nlm.nih.gov/9486592
https://pubmed.ncbi.nlm.nih.gov/9486592
Autor:
J. Benjamin Green, Stephanie Green, P. N. Grozea, Robert M. O'Bryan, Clarence B. Vaughn, Noboru Oishi, William S. Fletcher, Melvin L. Reed, Barbara Metch
Publikováno v:
Medical and Pediatric Oncology. 16:312-319
One hundred twenty-two patients with advanced adenocarcinoma of the breast were randomized to receive adriamycin (AD) alone or a combination of VP-16 plus lower dose adriamycin (VAD). The patients were stratified to good and poor risk. The starting d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d12542ad52140ef0e8b681c066076089
https://doi.org/10.1002/mpo.2950160505
https://doi.org/10.1002/mpo.2950160505
Publikováno v:
American Journal of Hematology. 20:119-128
Peripheral blood mononuclear cells from 11 patients with remission Hodgkin disease and 20 normal controls were incubated with irradiated allogeneic lymphocytes in one-way mixed lymphocyte cultures. Simultaneously, modified assays were performed by ad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6fd34392fbbe77720c90258008293af9
https://doi.org/10.1002/ajh.2830200204
https://doi.org/10.1002/ajh.2830200204
Publikováno v:
Cancer. 36:855-860
A series of 30 unselected patients with acute nonlymphoblastic leukemia (ANLL) was treated with combination chemotherapy, including three courses of cytosine arabinoside (Ara-C) by 5-day continuous i.v. infusion, vincristine i.v. weekly, and predniso
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2d5f9a401ab03d1f113fdb91e923be1f
https://doi.org/10.1002/1097-0142(197509)36:3<855::aid-cncr2820360304>3.0.co
https://doi.org/10.1002/1097-0142(197509)36:3<855::aid-cncr2820360304>3.0.co
Publikováno v:
Cancer treatment reports. 66(4)
Mature data from four clinical trials conducted by the Southwest Oncology Group from 1971 to 1978 for patients with all stages of Hodgkin's disease (HD) are reviewed in this paper. In the RAC #1 trial of stage I and II HD we demonstrated that involve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a0db63fa22a3f37e6c460687fcfe57a2
https://pubmed.ncbi.nlm.nih.gov/6176321
https://pubmed.ncbi.nlm.nih.gov/6176321
Autor:
S E, Jones, P N, Grozea, E N, Metz, A, Haut, R L, Stephens, F S, Morrison, R, Talley, J J, Butler, G E, Byrne, R, Hartsock, D, Dixon, S E, Salmon
Publikováno v:
Cancer. 51(6)
Between 1974 and 1977, 652 patients with non-Hodgkin's lymphoma without prior chemotherapy were randomized to 1 of 3 combination chemotherapy programs designed to induce complete remission (CR): COP-bleomycin (180 patients), CHOP-bleomycin (232 patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ed680b934a0dd4e4740e327bb117858b
https://pubmed.ncbi.nlm.nih.gov/6185212
https://pubmed.ncbi.nlm.nih.gov/6185212
Autor:
Thomas P. Miller, D A Lipschitz, Henry E. Wilson, P. N. Grozea, Stephen E. Jones, B Neilan, Dennis O. Dixon
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 4(3)
To study the influence of chronologic age on treatment outcome in patients with advanced, diffuse large-cell (histiocytic) lymphoma (DHL), we reviewed the results of two recent Southwest Oncology Group (SWOG) clinical trials. From 1974 to 1982, membe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7bff34331b3e48320116e18b63b91509
https://pubmed.ncbi.nlm.nih.gov/3512783
https://pubmed.ncbi.nlm.nih.gov/3512783
Autor:
Carol J. Fabian, C. A. ColtmanJr., E. J. Depersio, Francis S. Morrison, P. N. Grozea, Dennis O. Dixon, Stephen E. Jones
Publikováno v:
Malignant Lymphomas and Hodgkin’s Disease: Experimental and Therapeutic Advances ISBN: 9781461296324
The relapse-free survival (RFS) rate for Stage III Hodgkin’s disease treated by conventional total nodal irradiation (TNI) alone (early 1970’s) was disappointingly low [1–4]. The development of successful combination chemotherapy by National Ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5212c9656c8937a174498a2a276afa69
https://doi.org/10.1007/978-1-4613-2607-6_36
https://doi.org/10.1007/978-1-4613-2607-6_36
